Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015

Details for Mechanism ID: 9301
Country/Region: Uganda
Year: 2015
Main Partner: John Snow, Inc
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $8,342,746 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,763,006
Care: TB/HIV (HVTB) $308,703
Care: Pediatric Care and Support (PDCS) $504,595
Laboratory Infrastructure (HLAB) $50,000
Strategic Information (HVSI) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $104,715
Testing: HIV Testing and Counseling (HVCT) $1,860,678
Sexual Prevention: Other Sexual Prevention (HVOP) $353,375
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $614,636
Treatment: Adult Treatment (HTXS) $2,604,455
Treatment: Pediatric Treatment (PDTX) $178,583
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 3,391
CARE_CURR_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 344
CARE_CURR_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 6,622
CARE_CURR_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 407
CARE_CURR_DSD Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 10,764
CARE_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2016 10,764
CARE_NEW_DSD Aggregated Age/sex: <15 Female 2016 86
CARE_NEW_DSD Aggregated Age/sex: <15 Male 2016 76
CARE_NEW_DSD Aggregated Age/sex: 15+ Female 2016 1,498
CARE_NEW_DSD Aggregated Age/sex: 15+ Male 2016 815
CARE_NEW_DSD Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 2,475
CARE_NEW_DSD Sum of Aggregated Age/sex disaggregates 2016 2,475
CARE_NEW_TA Sum of Aggregated Age/sex disaggregates 2016 2,475
FN_THER_DSD Aggregated Age: <18 2016 102
FN_THER_DSD Aggregated Age: 18+ 2016 157
FN_THER_DSD Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2016 259
FN_THER_DSD Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2016 3,259
FN_THER_DSD Sum of Aggregated Age disaggregates 2016 259
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 8,708
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 63,488
HTC_TST_DSD By Test Result: Negative 2016 165,712
HTC_TST_DSD Sum of Aggregated Age/Sex <15 2016 20,253
HTC_TST_DSD Sum of Aggregated Age/Sex 15+ 2016 151,573
HTC_TST_DSD Sum of Aggregated Age/Sex disaggregates 2016 171,826
HTC_TST_DSD Sum of Test Result disaggregates 2016 171,826
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 44,999
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 33,950
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 342,981
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 247,270
HTC_TST_TA Sum of Aggregated Age/Sex <15 2016 78,949
HTC_TST_TA Sum of Aggregated Age/Sex 15+ 2016 590,251
HTC_TST_TA Sum of Aggregated Age/Sex disaggregates 2016 669,200
PMTCT_EID_DSD By infants who received a virologic test within 2 months of birth 2016 384
PMTCT_EID_DSD By infants who received their first virologic HIV test between 2 and 12 months of age 2016 43
PMTCT_EID_DSD Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 423
PMTCT_EID_DSD Sum of Infant Age disaggregates 2016 427
PMTCT_STAT_DSD By: Known positives at entry 2016 482
PMTCT_STAT_DSD By: Number of new positives identified 2016 51
PMTCT_STAT_DSD Number of new ANC and L&D clients 2016 11,914
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 11,320
PMTCT_STAT_DSD Sum of Positives Status disaggregates 2016 533
PMTCT_STAT_TA By: Known positives at entry 2016 3,810
PMTCT_STAT_TA By: Number of new positives identified 2016 425
PMTCT_STAT_TA Number of new ANC and L&D clients 2016 133,766
PMTCT_STAT_TA Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 127,076
PMTCT_STAT_TA Sum of Positives Status disaggregates 2016 4,235
PP_PREV_TA Age/sex: 10-14 Female 2016 19,588
PP_PREV_TA Age/sex: 10-14 Male 2016 14,836
PP_PREV_TA Age/sex: 15-19 Female 2016 32,870
PP_PREV_TA Age/sex: 15-19 Male 2016 26,636
PP_PREV_TA Age/sex: 20-24 Female 2016 48,523
PP_PREV_TA Age/sex: 20-24 Male 2016 29,012
PP_PREV_TA Age/sex: 25-49 Female 2016 70,308
PP_PREV_TA Age/sex: 25-49 Male 2016 51,147
PP_PREV_TA Age/sex: 50+ Female 2016 4,692
PP_PREV_TA Age/sex: 50+ Male 2016 4,399
PP_PREV_TA Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 302,011
PP_PREV_TA Sum of Age/Sex disaggregates 2016 302,011
TB_ART_DSD Aggregated Age: <15 2016 7
TB_ART_DSD Aggregated Age: 15+ 2016 85
TB_ART_DSD Female 2016 60
TB_ART_DSD Male 2016 32
TB_ART_DSD Sum of Aggregated Age disaggregates 2016 92
TB_ART_DSD Sum of Sex disaggregates 2016 92
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 115
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 92
TB_SCREEN_DSD Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2016 753
TB_SCREEN_DSD Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2016 10,009
TB_SCREEN_DSD Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 10,764
TB_SCREEN_DSD Sex: Female 2016 7,028
TB_SCREEN_DSD Sex: Male 2016 3,734
TB_SCREEN_DSD Sum of Aggregated Age disaggregates 2016 10,762
TB_SCREEN_DSD Sum of Sex disaggregates 2016 10,762
TB_SCREEN_DSD The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 10,762
TX_CURR_DSD Aggregated Age/Sex: 15+ Female 2016 2,754
TX_CURR_DSD Aggregated Age/Sex: 15+ Male 2016 5,977
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2016 9,426
TX_CURR_DSD Sum of Aggregated Age/Sex 15+ 2016 8,731
TX_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2016 8,731
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Female 2016 1,098
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Male 2016 2,318
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 3,566
TX_NEW_DSD Sum of Aggregated Age/Sex disaggregates 2016 3,416
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 3,047
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 3,586
Cross Cutting Budget Categories and Known Amounts Total: $100,000
Key Populations: MSM and TG $25,000
Training of health workers and community outreach workers
Collection and use of strategic information
Monitoring and evaluation of MSM/TG programs
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Key Populations: FSW $25,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Collection and use of strategic information on SWs and clients
Training of health workers and community outreach workers
Monitoring and evaluation of SW programs
Gender: Gender Based Violence (GBV) $30,000
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Gender: Gender Equality $20,000
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation